Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands. Issue 6 (22nd September 2021)

• Record Type: Journal Article
• Authors: Ma, Shirong; Zhao, Danhui; Liu, Yixiong; Rohr, Joseph; Zhang, Fan; Ma, Ying; Gong, Li; Shi, Huijuan; Wang, Yingmei; Fan, Linni; Qin, Junhui; Wang, Zhe; Guo, Shuangping
• Is Part Of: Histopathology. Volume 79:Issue 6(2022)
• Page Start: 1030
• Page End: 1039
• Publication Date: 2021-09-22
• Subjects: breast -- carcinoma ex pleomorphic adenoma -- PLAG1 gene rearrangement -- pleomorphic adenoma -- TRPS1–PLAG1 fusion; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.14461
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Aims: Pleomorphic adenoma (PA) of the breast, and especially its malignant transformation, is extremely rare and represents a diagnostic pitfall. Molecular alterations in this entity have not been investigated. We aimed to examine the clinicopathological features of our breast PAs and perform molecular analysis. Methods and results: Seven cases of breast PA, including two cases of carcinoma ex PA, were analysed. PLAG1 and HMGA2 gene rearrangements were assayed by fluorescence in‐situ hybridisation (FISH) and RNA sequencing (RNA‐Seq), respectively. Reverse transcription–polymerase chain reaction (RT–PCR) and Sanger sequencing were used to verify RNA sequencing results. All seven cases of breast PA occurred in women. The histological features were similar to the analogous tumour in salivary glands, including a dual epithelial–myoepithelial component and negativity of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) by immunohistochemistry. Of the two cases with carcinoma ex PA, one demonstrated minimal invasion and one was extensively invasive. PLAG1 rearrangements were identified in two cases (28.6%), but no rearrangements of HMG2A were found. A novel fusion product in PAs, TRPS1–PLAG1, was identified in one case. No patients had recurrence or metastasis with a follow‐up period of 6–158 months. Conclusions: Breast PA is rare, but it is an important differential diagnosis of breast pathology with the potential to develop carcinoma ex PA. We report a novel TRPS1–PLAG1 fusion gene in breast PA. Abstract :